Use of modeling to evaluate the cost-effectiveness of cancer screening programs.
about
Adopting helical CT screening for lung cancer: potential health consequences during a 15-year periodCalibration methods used in cancer simulation models and suggested reporting guidelinesComparing upper gastrointestinal X-ray and endoscopy for gastric cancer diagnosis in KoreaEstimating long-term effectiveness of lung cancer screening in the Mayo CT screening study.Can mechanical imaging increase the specificity of mammography screening?Comparative economic evaluation of data from the ACRIN National CT Colonography Trial with three cancer intervention and surveillance modeling network microsimulations.Risk-specific optimal cancer screening schedules: an application to breast cancer early detectionDealing with Time in Health Economic Evaluation: Methodological Issues and Recommendations for Practice.Chapter 13: CISNET lung models: comparison of model assumptions and model structures.Derivation of background mortality by smoking and obesity in cancer simulation models.Cost of a 5-year lung cancer survivor: symptomatic tumour identification vs proactive computed tomography screening.Cost-effectiveness of Prostate Health Index for prostate cancer detection.Phase II study of a combination of irinotecan and S-1 in patients with advanced gastric cancer (OGSG0002).Determining the cost-effectiveness of endoscopic surveillance for gastric cancer in patients with precancerous lesions.Applying reinforcement learning techniques to detect hepatocellular carcinoma under limited screening capacity.The influence of disease risk on the optimal time interval between screens for the early detection of cancer: a mathematical approach.
P2860
Q28392207-8AB3EBF6-6E13-4E58-9B5A-17FA5ACC1694Q28749665-C66CA507-C4B8-4A19-A49D-E4C1813C2795Q33590835-EBF8F513-F765-4CE7-85E9-CBD7B0215C54Q33620462-E6D94659-3397-42A0-B60C-B9AAB18FD4F2Q33854497-4327E2DE-F175-4894-A065-FBD2D2C702A6Q33981053-8E07EA12-FC28-4706-BD40-1E5DB1C4E541Q35591304-E0BEA6D8-D16B-442D-984D-AEFEC30F3A9DQ36322923-DE8D51A3-AE1B-4716-85F6-B8407D6FA995Q36340123-DD44E699-E8D8-4579-A64D-F777B54D15E0Q36873349-C4035562-319C-4425-A06E-34CBC77D9049Q37345335-5B2DBBF8-2BFC-4E5C-BD42-3B20112B2C12Q40007049-7F1DF321-0F30-4B62-ACF6-29973F4B9B77Q46707260-AE192ADE-E2ED-4FFB-9EB7-B0EBE907042AQ46766347-A1EE91B4-1C23-41D4-B43D-8B61808EC819Q50629271-D65AEA49-A32E-42A6-9A3A-8BA6A1DACF68Q51093556-BB876B5D-18C5-41BD-804E-7FB5F2F236BF
P2860
Use of modeling to evaluate the cost-effectiveness of cancer screening programs.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Use of modeling to evaluate the cost-effectiveness of cancer screening programs.
@ast
Use of modeling to evaluate the cost-effectiveness of cancer screening programs.
@en
type
label
Use of modeling to evaluate the cost-effectiveness of cancer screening programs.
@ast
Use of modeling to evaluate the cost-effectiveness of cancer screening programs.
@en
prefLabel
Use of modeling to evaluate the cost-effectiveness of cancer screening programs.
@ast
Use of modeling to evaluate the cost-effectiveness of cancer screening programs.
@en
P356
P1476
Use of modeling to evaluate the cost-effectiveness of cancer screening programs.
@en
P2093
Amy B Knudsen
G Scott Gazelle
P304
P356
10.1200/JCO.2006.07.9202
P407
P577
2007-01-01T00:00:00Z